P/E ratio for Apollo Endosurgery (APEN)
P/E ratio as of May 2024 (TTM): -9.80
According to Apollo Endosurgery's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -9.80392. At the end of 2021 the company had a P/E ratio of -10.8.
P/E ratio history for Apollo Endosurgery from 2006 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -10.8 | |
| 2019 | -2.24 | 48.96% |
| 2018 | -1.51 | -42.16% |
| 2017 | -2.60 | 1061.06% |
| 2016 | -0.2243 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 44.3 | -551.50% | 🇺🇸 USA |
 Inari Medical
NARI | -840 | 8,465.96% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.